Table 1 from First-in-Human Phase I/II Study of INCAGN01876, a Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist, in Patients with Advanced or Metastatic Solid Tumors
Year: 2025
Type: other
Abstract: Baseline demographics and characteristics.
Authors: Omid Hamid, Dana B. Cardin, F. Stephen Hodi, Patricia LoRusso, Taha Merghoub, Roberta Zappasodi, Rachana Maniyar, John E. Janik, Maikel V.W. van der Velden, Feng Zhou, Zhiwan Dong, Xuejun Chen, James J. Harding
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4414747901
Cites:
Cited by:
Related to: